DVT - Nursing Case Study

Pathophysiology

• Primary mechanism: Venous stasis occurs when blood flow through the veins is slow or obstructed, often due to immobilization or prolonged bed rest, leading to increased risk of clot formation in the deep veins of the legs.

• Secondary mechanism: Hypercoagulability, often from inherited conditions or acquired factors like surgery or malignancy, increases the blood's tendency to clot, exacerbating thrombus formation.

• Key complication: If a clot breaks free, it can travel to the lungs, causing a potentially life-threatening pulmonary embolism, necessitating prompt recognition and treatment to prevent severe outcomes.

Patient Profile

Demographics:

45-year-old male, construction worker

History:

• Key past medical history: Hypertension, obesity, smoking (15 pack years)

• Current medications: Lisinopril 10 mg daily, Atorvastatin 20 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Swelling and pain in the left leg

• Key symptoms: Warmth and redness in the left calf, difficulty walking, mild shortness of breath

• Vital signs: Blood pressure 150/95 mmHg, heart rate 105 bpm, respiratory rate 22 breaths per minute, temperature 37.8°C (100.0°F), oxygen saturation 93% on room air

Section 1

As the medical team continues to monitor the patient, Mr. Johnson, new diagnostic results from a Doppler ultrasound of his left leg confirm the presence of a deep vein thrombosis (DVT) in the popliteal vein. Given his obesity, smoking history, and hypertension, these findings are consistent with an increased risk of venous thromboembolism. In light of these results, the medical team initiates anticoagulation therapy with low molecular weight heparin as a bridging strategy before transitioning to oral anticoagulants. This intervention aims to prevent further clot propagation and reduce the risk of a pulmonary embolism.

However, within 24 hours of starting treatment, Mr. Johnson experiences a change in his respiratory status. His shortness of breath intensifies, and he develops a persistent cough with hemoptysis. His oxygen saturation drops to 88% on room air, prompting the healthcare providers to administer supplemental oxygen. A chest CT with contrast reveals multiple small pulmonary emboli in the branches of the right lower lobe. This complication highlights the critical nature of rapid intervention and heightens the urgency to adjust his management plan to address these new findings.

The emergence of pulmonary emboli necessitates an escalation in care, including possible consideration of thrombolytic therapy if Mr. Johnson's respiratory distress worsens. The healthcare team must now closely monitor his respiratory and cardiovascular status, adjusting anticoagulation therapy as necessary while managing any potential bleeding risks. This situation calls for the integration of clinical reasoning skills to balance anticoagulation benefits against potential adverse effects, ensuring Mr. Johnson receives comprehensive care to stabilize his condition and prevent further complications.

Section 2

As Mr. Johnson's condition evolves, the healthcare team remains vigilant in monitoring his status and response to interventions. Within hours of initiating supplemental oxygen, his respiratory rate continues to remain elevated at 24 breaths per minute, and his dyspnea persists despite oxygen therapy. His vital signs reveal a blood pressure of 148/92 mmHg and a heart rate of 110 beats per minute, indicating a compensatory response to his respiratory distress. Arterial blood gas analysis shows a slight respiratory alkalosis with a pH of 7.47, PaCO2 of 32 mmHg, and PaO2 of 64 mmHg on 4 liters per minute of nasal cannula oxygen. These findings are consistent with acute respiratory compromise secondary to the diagnosed pulmonary emboli.

Given the moderate complexity of his condition, the medical team decides to adjust Mr. Johnson's anticoagulation regimen. They opt to increase the dosage of low molecular weight heparin while closely monitoring his coagulation parameters, including activated partial thromboplastin time (aPTT) and anti-factor Xa levels, to ensure therapeutic anticoagulation without predisposing him to bleeding. Concurrently, they initiate a more aggressive respiratory management plan, including consideration of non-invasive positive pressure ventilation to improve his oxygenation and reduce work of breathing.

The team also orders a repeat Doppler ultrasound to assess for any extension of the DVT, as well as a complete blood count and comprehensive metabolic panel to evaluate for potential complications such as heparin-induced thrombocytopenia or electrolyte imbalances. The emergence of these complications necessitates a multidisciplinary approach, engaging pulmonologists, cardiologists, and hematologists to refine his care plan. This coordinated effort is crucial to stabilize Mr. Johnson and prevent further deterioration, underscoring the importance of integrating clinical reasoning and timely interventions in managing complex cases like his.

Section 3

As the healthcare team continues to monitor Mr. Johnson's condition, they observe a change in his patient status that prompts further investigation. Despite the adjustments to his anticoagulation regimen and the implementation of non-invasive positive pressure ventilation, Mr. Johnson begins to exhibit signs of increased fatigue and confusion. His vital signs reveal a heart rate now elevated to 120 beats per minute and a blood pressure of 152/94 mmHg, while his oxygen saturation fluctuates between 89% and 92% on the current respiratory support. These changes raise concerns about the adequacy of tissue perfusion and oxygenation.

New diagnostic results from the repeat Doppler ultrasound show an extension of the deep vein thrombosis into the proximal veins, which may be contributing to the increased burden on his cardiovascular system. Additionally, laboratory tests reveal a mild drop in platelet count, raising the suspicion of heparin-induced thrombocytopenia (HIT). The comprehensive metabolic panel indicates mild hypokalemia with a potassium level of 3.4 mmol/L, which could have implications for cardiac function and necessitate electrolyte repletion.

Faced with these developments, the multidisciplinary team reevaluates their approach, considering alternative anticoagulation options such as direct oral anticoagulants (DOACs) to mitigate the risk of HIT. They also prioritize correcting the electrolyte imbalance and intensify monitoring of Mr. Johnson's neurological status, recognizing the potential for further complications if his confusion worsens. This nuanced clinical reasoning highlights the need for dynamic adaptation of the treatment plan, ensuring that all aspects of Mr. Johnson's care are addressed comprehensively to optimize his recovery and prevent further deterioration.

Section 4

Following the multidisciplinary team's decision to switch Mr. Johnson to a direct oral anticoagulant (DOAC), his anticoagulation therapy is carefully adjusted to mitigate the risk of heparin-induced thrombocytopenia. In parallel, the team initiates potassium supplementation to address the mild hypokalemia, aiming to stabilize his cardiac function. Over the next 24 hours, the healthcare team closely monitors Mr. Johnson's response to these interventions. They observe a gradual improvement in his oxygen saturation, which stabilizes around 93% to 94% with continued respiratory support, and a slight decrease in heart rate to 110 beats per minute. Blood pressure remains elevated at 148/90 mmHg, indicating the need for ongoing cardiovascular monitoring.

However, despite the positive trends in some areas, Mr. Johnson's neurological status remains concerning. His confusion persists and is now accompanied by episodes of restlessness and agitation. The team suspects that these symptoms could be a sign of cerebral hypoxia or a potential embolic event. A stat CT scan of the head is ordered to rule out any acute neurological complications such as a stroke. Additionally, arterial blood gases are obtained, revealing a pH of 7.32 and a pCO2 of 48 mmHg, suggesting a respiratory acidosis likely secondary to hypoventilation.

These findings prompt the healthcare team to further investigate the possibility of a pulmonary embolism (PE) as the source of Mr. Johnson's ongoing respiratory and neurological challenges. A CT pulmonary angiogram is scheduled to assess for any thromboembolic events in the pulmonary vasculature. The team remains vigilant, recognizing that the presence of a PE could significantly impact Mr. Johnson's prognosis and treatment strategy. This critical juncture highlights the complexity of his case, requiring a coordinated and adaptive approach to manage the evolving complications and optimize his chances for recovery.

Section 5

The CT pulmonary angiogram confirms the presence of multiple small emboli in the distal branches of Mr. Johnson's pulmonary arteries, corroborating the suspicion of a pulmonary embolism. This development underscores the need for an urgent reassessment of his anticoagulation strategy. Given the confirmed PE and the risk of further embolic events, the multidisciplinary team deliberates on optimizing the dosage of the direct oral anticoagulant while ensuring Mr. Johnson remains within safe therapeutic parameters. The team also considers the potential need for supplemental oxygen therapy adjustments or, if necessary, non-invasive ventilation support to enhance his oxygenation and reduce the work of breathing.

Concurrently, the results of the CT scan of Mr. Johnson's head reveal no acute intracranial abnormalities, providing some relief. However, given the respiratory acidosis noted in the arterial blood gases and the confirmed PE, the team now attributes Mr. Johnson's confusion, restlessness, and agitation to a combination of cerebral hypoxia and metabolic disturbances. The healthcare team initiates a more aggressive management plan to correct the respiratory acidosis by encouraging more effective ventilation. They also implement frequent neurological assessments to monitor for any changes that might suggest worsening cerebral perfusion.

As Mr. Johnson continues under close observation, his blood pressure shows a slight decrease to 142/88 mmHg, yet it remains a focal point of the cardiovascular management plan. The team remains cautious, acknowledging that the resolution of the PE will take time and that consistent monitoring and adaptation of the treatment plan are essential. This phase of Mr. Johnson's care emphasizes the need for precise coordination across disciplines to address the complex interplay of his respiratory and neurological conditions. The team remains hopeful that these interventions will stabilize his condition and ultimately lead to improved clinical outcomes.